These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18435675)

  • 1. Quality control of recovered plasma for fractionation: an extensive Italian study.
    Grazzini G; Rossi G; Rafanelli D; Gambelli D; Farina C; Mori F; Zucchelli P; Marchiori G; Breda A; Liumbruno GM
    Transfusion; 2008 Jul; 48(7):1459-68. PubMed ID: 18435675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of temperature on plasma freezing under industrial conditions.
    Bravo MI; Grancha S; Jorquera JI
    Pharmeur Sci Notes; 2006 Aug; 2006(1):31-5. PubMed ID: 17694644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction.
    O'Donnell J; Tuddenham EG; Manning R; Kemball-Cook G; Johnson D; Laffan M
    Thromb Haemost; 1997 May; 77(5):825-8. PubMed ID: 9184386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quality of fresh-frozen plasma produced from whole blood stored at 4 degrees C overnight.
    Cardigan R; Lawrie AS; Mackie IJ; Williamson LM
    Transfusion; 2005 Aug; 45(8):1342-8. PubMed ID: 16078924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-receptor blockade decreases elevated plasma levels of factor VIII:C in patients with deep vein thrombosis.
    Hoppener MR; Kraaijenhagen RA; Hutten BA; Büller HR; Peters RJ; Levi M
    J Thromb Haemost; 2004 Aug; 2(8):1316-20. PubMed ID: 15304037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort.
    Morange PE; Tregouet DA; Frere C; Saut N; Pellegrina L; Alessi MC; Visvikis S; Tiret L; Juhan-Vague I
    Br J Haematol; 2005 Jan; 128(1):91-9. PubMed ID: 15606554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers.
    Schlenke P; Hervig T; Isola H; Wiesel ML; Kientz D; Pinkoski L; Singh Y; Lin L; Corash L; Cazenave JP
    Transfusion; 2008 Apr; 48(4):697-705. PubMed ID: 18194378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thai national reference preparation in blood coagulation. IV. Home made reference plasma for von Willebrand's factor assay.
    Talalak P; Luenee P; Opartkiattikul N; Sangtawisin V
    J Med Assoc Thai; 1993 Oct; 76(10):570-5. PubMed ID: 7964228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand factor: evidence for variable clearance in vivo according to Y/C1584 phenotype and ABO blood group.
    Davies JA; Collins PW; Hathaway LS; Bowen DJ
    J Thromb Haemost; 2008 Jan; 6(1):97-103. PubMed ID: 17949477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C).
    Shima M; Matsumoto T; Fukuda K; Kubota Y; Tanaka I; Nishiya K; Giles AR; Yoshioka A
    Thromb Haemost; 2002 Mar; 87(3):436-41. PubMed ID: 11916076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
    Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V
    Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 degrees C for 6 days.
    Buchta C; Felfernig M; Höcker P; Macher M; Körmöczi GF; Quehenberger P; Heinzl H; Knöbl P
    Vox Sang; 2004 Oct; 87(3):182-6. PubMed ID: 15569070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quality of plasma collected by automated apheresis and of recovered plasma from leukodepleted whole blood.
    Runkel S; Haubelt H; Hitzler W; Hellstern P
    Transfusion; 2005 Mar; 45(3):427-32. PubMed ID: 15752162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.
    Osselaer JC; Debry C; Goffaux M; Pineau J; Calomme G; Dubuc E; Chatelain B; Vandendaele MC; Hsu J; Rheinschmidt M; Lin L
    Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation parameters in apheresis and leukodepleted whole-blood plasma during storage.
    Boström F; Sjödahl M; Wehlin L; Egberg N; Lundahl J
    Transfusion; 2007 Mar; 47(3):460-3. PubMed ID: 17319826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryoprecipitate prepared from plasma treated with methylene blue plus light: increasing the fibrinogen concentration.
    Hornsey VS; Young DA; Docherty A; Hughes W; Prowse CV
    Transfus Med; 2004 Oct; 14(5):369-74. PubMed ID: 15500456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful surgical haemostasis in patients with von Willebrand disease with Koate DVI.
    Viswabandya A; Mathews V; George B; Nair SC; Baidya S; Mammen JJ; Chandy M; Srivastava A
    Haemophilia; 2008 Jul; 14(4):763-7. PubMed ID: 18445014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters.
    van Veen JJ; Gatt A; Cooper PC; Kitchen S; Bowyer AE; Makris M
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):183-9. PubMed ID: 18388496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial elevated factor VIII in children with symptomatic venous thrombosis and post-thrombotic syndrome: results of a multicenter study.
    Kreuz W; Stoll M; Junker R; Heinecke A; Schobess R; Kurnik K; Kelsch R; Nowak-Göttl U
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1901-6. PubMed ID: 16709943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins.
    Hornsey VS; Drummond O; Morrison A; McMillan L; MacGregor IR; Prowse CV
    Transfusion; 2009 Oct; 49(10):2167-72. PubMed ID: 19555414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.